MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search
  • 2019 International Congress

    Successful late rehabilitation based on botulinum therapy

    T. Kuznetsova, A. Svetkina (Samara, Russian Federation)

    Objective: Hemiparesis of various severity is the most common stroke side effect. On average 30-40% of stroke survivors develop post-stroke spasticity. The best neuroplasticity enabling…
  • 2019 International Congress

    Abnormal thalamo-cortical functional connectivity patterns in Gilles de la Tourette Syndrome: a seed-based resting state fMRI study

    L. Zapparoli, M. Porta, F. Devoto, N. Tedone, D. Servello, E. Paulesu (Milan, Italy)

    Objective: Here we directly tested this hypothesis and we investigated the specific functional connectivity patterns of thalamic motor seeds in 24 GTS patients and 24…
  • 2019 International Congress

    The Prevalence of Essential Tremor in Edirne and Its Districts Concomitant Comorbid Conditions

    S. Güler, A. Caylan, N. Turan (Edirne, Turkey)

    Objective: We aimed to determine the prevalence and risk factors of Essential Tremor (ET) in Edirne and its districts, located in Western Thrace, which is…
  • 2019 International Congress

    Orthostatic jaw tremor, a diagnostic challenge

    R. Moraes, F. Sousa, P. Pereira, J. Freitas, L. Santos, J. Junior, M. Rocha (Sao Paulo, Brazil)

    Objective: To present a rare movement disorder of an orthostatic jaw tremor and a remarkable benefit from treatment with botulinum toxin A Background: Jaw tremor…
  • 2019 International Congress

    Is VIM-DBS in ET-plus patients as effective as in ET patients?

    J. Steffen, J. Petry-Schmelzer, T. Dembek, J. Becker, G. Fink, V. Visser-Vandewalle, M. Barbe (Cologne, Germany)

    Objective: To compare the effect of deep brain stimulation (DBS) of the ventral intermediate nucleus (VIM) in patients with Essential Tremor (ET) and ET-plus (ET-p).…
  • 2019 International Congress

    Long-Term Outcomes in Patients with Tardive Dyskinesia who Were Early Responders with Valbenazine

    S. Factor, C. Comella, S. Marder, J. Burke, K. Farahmand, S. Siegert (Atlanta, GA, USA)

    Objective: To assess the long-term outcomes of once-daily valbenazine (VBZ) on tardive dyskinesia (TD) using a formal assessment (Abnormal Involuntary Movement Scale [AIMS]) in participants…
  • 2019 International Congress

    Re-emerging Neuroleptic Malignant Syndrome (NMS) without Re-introduced Neuroleptic in a Schizophrenia Patient: a Case Report

    D. Tunjungsari, A. Tiksnadi (Jakarta, Indonesia)

    Objective: To report a case with re-emerging neuroleptic malignant syndrome (NMS) without re-introduced neuroleptic drugs. Background: Neuroleptic Malignant Syndrome (NMS) is a potentially fatal idiosyncratic…
  • 2019 International Congress

    Apathy and cognitive profile in Parkinson´s disease: A cross-sectional study in Cali-Colombia

    B. Muñoz, J. Valderrama, L. Botero, J. Orozco (Cali, Colombia)

    Objective: To describe and correlate the apathy and cognitive profile of patients with Parkinson’s disease (PD). Background: Prevalence of apathy in PD is highly variable…
  • 2019 International Congress

    Influence of controlled-release levodopa on quality of sleep and nocturnal movements

    E. Schaeffer, L. Zaunbrecher, I. Liepelt-Scarfone, C. Hansen, W. Maetzler, S. Nussbaum, B. Roeben, M. Elshehabi, P. Saraykin, S. Otterbein, J. Busch, D. Berg (Kiel, Germany)

    Objective: To evaluate the effects of controlled-released (CR) levodopa on quality of sleep and nocturnal movements as assessed with mobile health technology in patients with…
  • 2019 International Congress

    Characteristics of lower gastrointestinal tract dysfunction in patients with Parkinson disease

    T. Uchiyama, T. Yamamoto, K. Suzuki, T. Kadowaki, H. Nakajima, R. Sakakibara, S. Kuwabara, K. Hirata, M. Murai (Chiba, Japan)

    Objective: To evaluate the characteristics of lower gastrointestinal tract dysfunction in patients with Parkinson disease (PD). Background: Lower gastrointestinal tract dysfunction is common in patients…
  • « Previous Page
  • 1
  • …
  • 62
  • 63
  • 64
  • 65
  • 66
  • …
  • 217
  • Next Page »

Most Viewed Abstracts

  • This Week
  • This Month
  • All Time
  • #23285 (not found)
  • The hardest symptoms that bother patients with Parkinson's disease
  • Life expectancy with and without Parkinson’s disease in the general population
  • Effect of marijuana on Essential Tremor: A case report
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Estimation of the 2020 Global Population of Parkinson’s Disease (PD)
  • Patients with Essential Tremor Live Longer than their Relatives
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley